Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00005827
What this trial is testing

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00585962
What this trial is testing

Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 57
Testing effectiveness (Phase 2)Ended earlyNCT00058214
What this trial is testing

Perifosine in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00450411
What this trial is testing

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 100
Large-scale testing (Phase 3)Study completedNCT00127478
What this trial is testing

A Long Term Safety Study With Atrasentan

Who this might be right for
Prostate CancerAdenocarcinoma
Abbott 166
Not applicableWithdrawnNCT04399824
What this trial is testing

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00016107
What this trial is testing

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT00003607
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 450
Testing effectiveness (Phase 2)Study completedNCT00570700
What this trial is testing

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
University of California, Irvine 38
Testing effectiveness (Phase 2)Study completedNCT00252941
What this trial is testing

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Who this might be right for
Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT01799278
What this trial is testing

A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer

Who this might be right for
Small Cell Prostate CancerNeuroendocrine Prostate CancerProstate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Ended earlyNCT00503984
What this trial is testing

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerPain
University of Miami 22
Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Not applicableLooking for participantsNCT03880422
What this trial is testing

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Who this might be right for
Cancer SurvivorObesityOverweight+17 more
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT00561262
What this trial is testing

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 60
Testing effectiveness (Phase 2)Ended earlyNCT00634582
What this trial is testing

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
Wake Forest University Health Sciences 2
Not applicableStudy completedNCT00402285
What this trial is testing

Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 84
Testing effectiveness (Phase 2)Ended earlyNCT00526591
What this trial is testing

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Jorge A. Garcia, MD 17
Next Page